ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021
Directed Design of a Au
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 26 citations in OpenAlex.
- Exploring Mesoionic Imine-Carbodiimide (MII-CDI) Adducts: 1,3 H-Shift, N(I) Compounds and Guanidinate-Type Ligands.Angewandte Chemie (International ed. in English) · 2025Article
- AuInternational journal of molecular sciences · 2025Article
- Application of first-row transition metal complexes bearing 1,2,3-triazolylidene ligands in catalysis and beyond.Chemical Society reviews · 2024Review
- Impact of Bidentate Pyridyl-Mesoionic Carbene Ligands: Structural, (Spectro)Electrochemical, Photophysical, and Theoretical Investigations on Ruthenium(II) Complexes.ACS organic & inorganic Au · 2023Article
- Reactivity and Structure of a Bis-phenolate Niobium NHC Complex.ACS organic & inorganic Au · 2023Article
- Gauging Radical Stabilization with Carbenes.Angewandte Chemie (International ed. in English) · 2022Article
- Mesoionic Imines (MIIs): Strong Donors and Versatile Ligands for Transition Metals and Main Group Substrates.Angewandte Chemie (International ed. in English) · 2022Article
- A Mesoionic Diselenolene Anion and the Corresponding Radical Dianion.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- 4-Phenyl-1,2,3-triazoles as Versatile Ligands for Cationic Cyclometalated Iridium(III) Complexes.Inorganic chemistry · 2022Article
- Review
- Mesoionic Carbenes in Low- to High-Valent Vanadium Chemistry.Inorganic chemistry · 2021Article
- Tuning the π-Accepting Properties of Mesoionic Carbenes: A Combined Computational and Experimental Study.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- Directed Design of a AuChemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbene-based radicals are important for both fundamental and applied chemical research. Herein, extensive electrochemical investigations of nine different 1,2,3-triazolylidene selenium adducts are reported. It is found that the half-wave potentials of the first reduction of the selones correlate with their calculated LUMO levels and the LUMO levels of the corresponding triazolylidene-based mesoionic carbenes (MICs). Furthermore, unexpected quasi-reversibility of the reduction of two triazoline selones, exhibiting comparable reduction potentials, was discovered. Through UV/Vis/NIR and EPR spectroelectrochemical investigations supported by DFT calculations, the radical anion was unambiguously assigned to be triazoline centered. This electrochemical behavior was transferred to a triazolylidene-type MIC-gold phenyl complex resulting in a MIC-radical coordinated Au
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.